FR15C0082I1 - VACCINE AGAINST HPV16 AND HPV18 VIRUSES AND AT LEAST ONE OTHER TYPE OF HPV SELECTED AMONG HPV 31, 45 OR 52 - Google Patents
VACCINE AGAINST HPV16 AND HPV18 VIRUSES AND AT LEAST ONE OTHER TYPE OF HPV SELECTED AMONG HPV 31, 45 OR 52Info
- Publication number
- FR15C0082I1 FR15C0082I1 FR15C0082C FR15C0082I1 FR 15C0082 I1 FR15C0082 I1 FR 15C0082I1 FR 15C0082 C FR15C0082 C FR 15C0082C FR 15C0082 I1 FR15C0082 I1 FR 15C0082I1
- Authority
- FR
- France
- Prior art keywords
- hpv
- type
- vaccine against
- against hpv16
- hpv18
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0413510.9A GB0413510D0 (en) | 2004-06-16 | 2004-06-16 | Vaccine |
US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
PCT/EP2005/006461 WO2005123125A1 (en) | 2004-06-16 | 2005-06-14 | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR15C0082I1 true FR15C0082I1 (en) | 2016-01-08 |
FR15C0082I2 FR15C0082I2 (en) | 2016-10-28 |
Family
ID=35160037
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR15C0082C Active FR15C0082I2 (en) | 2004-06-16 | 2015-12-04 | VACCINE AGAINST HPV16 AND HPV18 VIRUSES AND AT LEAST ONE OTHER TYPE OF HPV SELECTED AMONG HPV 31, 45 OR 52 |
FR15C0084C Active FR15C0084I2 (en) | 2004-06-16 | 2015-12-04 | VACCINE AGAINST HPV16 AND HPV18 VIRUSES AND AT LEAST ONE OTHER TYPE OF HPV SELECTED AMONG HPV 31, 45 OR 52 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR15C0084C Active FR15C0084I2 (en) | 2004-06-16 | 2015-12-04 | VACCINE AGAINST HPV16 AND HPV18 VIRUSES AND AT LEAST ONE OTHER TYPE OF HPV SELECTED AMONG HPV 31, 45 OR 52 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1758609B1 (en) |
JP (1) | JP2008502633A (en) |
KR (1) | KR20070029254A (en) |
AR (1) | AR049354A1 (en) |
AU (1) | AU2005253723B2 (en) |
BR (1) | BRPI0512042B8 (en) |
CA (1) | CA2566620C (en) |
FR (2) | FR15C0082I2 (en) |
IL (1) | IL179138A0 (en) |
LU (3) | LU92899I2 (en) |
MA (1) | MA28692B1 (en) |
MX (1) | MXPA06014515A (en) |
NO (1) | NO20070195L (en) |
PE (1) | PE20060434A1 (en) |
PL (1) | PL1758609T3 (en) |
RU (1) | RU2420313C2 (en) |
SG (1) | SG153837A1 (en) |
WO (1) | WO2005123125A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA013325B1 (en) * | 2005-04-26 | 2010-04-30 | Глаксосмитклайн Байолоджикалс С.А. | Vaccine |
JP6022159B2 (en) * | 2008-07-31 | 2016-11-09 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Anti-HPV vaccine |
EP2444103B1 (en) * | 2009-06-19 | 2017-12-20 | Eyegene Inc. | Vaccine for cervical cancer |
NZ606949A (en) * | 2010-07-15 | 2015-11-27 | British Columbia Cancer Agency | Human papillomavirus e7 antigen compositions and uses thereof |
RU2015121828A (en) | 2012-10-30 | 2016-12-20 | Пфайзер Инк | VACCINES BASED ON RECOMBINANT PARTICLES AGAINST HUMAN CYTOMEGALOVIRUS INFECTION |
BR112017008280A2 (en) * | 2014-10-24 | 2018-01-02 | Hpvvax, Llc. | method for treating a patient |
CN107188966B (en) | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | Papilloma virus chimeric protein and application thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
US6908613B2 (en) * | 2000-06-21 | 2005-06-21 | Medimmune, Inc. | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
WO2004056389A1 (en) * | 2002-12-20 | 2004-07-08 | Glaxosmithkline Biologicals Sa | Hpv-16 and -18 l1 vlp vaccine |
-
2005
- 2005-06-14 PL PL05757953T patent/PL1758609T3/en unknown
- 2005-06-14 MX MXPA06014515A patent/MXPA06014515A/en active IP Right Grant
- 2005-06-14 AU AU2005253723A patent/AU2005253723B2/en active Active
- 2005-06-14 AR ARP050102434A patent/AR049354A1/en not_active Application Discontinuation
- 2005-06-14 PE PE2005000677A patent/PE20060434A1/en not_active Application Discontinuation
- 2005-06-14 EP EP05757953A patent/EP1758609B1/en active Active
- 2005-06-14 JP JP2007515878A patent/JP2008502633A/en active Pending
- 2005-06-14 CA CA2566620A patent/CA2566620C/en active Active
- 2005-06-14 KR KR1020077001065A patent/KR20070029254A/en active Application Filing
- 2005-06-14 SG SG200904200-3A patent/SG153837A1/en unknown
- 2005-06-14 RU RU2006143804/10A patent/RU2420313C2/en active
- 2005-06-14 BR BRPI0512042A patent/BRPI0512042B8/en active IP Right Grant
- 2005-06-14 WO PCT/EP2005/006461 patent/WO2005123125A1/en active Application Filing
-
2006
- 2006-11-09 IL IL179138A patent/IL179138A0/en unknown
- 2006-12-28 MA MA29576A patent/MA28692B1/en unknown
-
2007
- 2007-01-11 NO NO20070195A patent/NO20070195L/en not_active Application Discontinuation
-
2015
- 2015-12-04 FR FR15C0082C patent/FR15C0082I2/en active Active
- 2015-12-04 FR FR15C0084C patent/FR15C0084I2/en active Active
- 2015-12-08 LU LU92899C patent/LU92899I2/en unknown
- 2015-12-08 LU LU92898C patent/LU92898I2/en unknown
- 2015-12-08 LU LU92900C patent/LU92900I2/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2566620A1 (en) | 2005-12-29 |
FR15C0084I1 (en) | 2016-01-08 |
RU2420313C2 (en) | 2011-06-10 |
FR15C0084I2 (en) | 2016-10-28 |
AU2005253723B2 (en) | 2011-01-20 |
LU92898I2 (en) | 2016-03-08 |
CA2566620C (en) | 2014-03-11 |
JP2008502633A (en) | 2008-01-31 |
AU2005253723A1 (en) | 2005-12-29 |
SG153837A1 (en) | 2009-07-29 |
NO20070195L (en) | 2007-01-15 |
BRPI0512042B1 (en) | 2019-01-22 |
PL1758609T3 (en) | 2013-02-28 |
AR049354A1 (en) | 2006-07-19 |
BRPI0512042A (en) | 2008-02-06 |
EP1758609B1 (en) | 2012-10-03 |
IL179138A0 (en) | 2007-03-08 |
KR20070029254A (en) | 2007-03-13 |
WO2005123125A1 (en) | 2005-12-29 |
MXPA06014515A (en) | 2007-03-23 |
FR15C0082I2 (en) | 2016-10-28 |
PE20060434A1 (en) | 2006-06-08 |
MA28692B1 (en) | 2007-06-01 |
LU92900I2 (en) | 2016-03-08 |
LU92899I2 (en) | 2016-03-08 |
BRPI0512042B8 (en) | 2021-05-25 |
EP1758609A1 (en) | 2007-03-07 |
RU2006143804A (en) | 2008-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR15C0082I2 (en) | VACCINE AGAINST HPV16 AND HPV18 VIRUSES AND AT LEAST ONE OTHER TYPE OF HPV SELECTED AMONG HPV 31, 45 OR 52 | |
NO2017005I1 (en) | Human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] | |
ECSP045300A (en) | VIRAL ANTIGENS | |
AP2313A (en) | Inhibitors of hepatitis C virus RNA-dependent RNA ploymerase, and compositions and treatments using the same. | |
BRPI0309631A2 (en) | tetravalent dengue vaccine containing a trivial deletion of 30 nucleotides in the utr-31 'of dengue types 1,2,3, and 4, or chimeric dengue antigenic viruses 1,2,3 and 4 | |
IL189329A (en) | Vaccination against dengue virus infection, kit and use of same | |
WO2009039248A3 (en) | Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection | |
HK1085378A1 (en) | Use of hpv16 and hpv18 as vaccine against one or more of oncogenic hpv type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | |
WO2010047830A3 (en) | Agents for hcv treatment | |
AU2003246373A1 (en) | Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions | |
HUS1500059I1 (en) | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 | |
NO20053348D0 (en) | Pharmaceutical composition for the treatment of viral attacks. | |
MY149395A (en) | Pharmaceutical compound capable of induce immune protective response against dengue virus having the capsid protein of the dengue virus | |
EP1765330A4 (en) | Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease | |
AU2005279590A1 (en) | Vaccine composition against hepatitis C virus | |
WO2005023849A3 (en) | Antigenic peptides of rabies virus and uses thereof | |
WO2007076091A3 (en) | Treatment of viral infections using a tissue factor inhibitor | |
FR15C0080I2 (en) | VACCINE AGAINST HPV16 AND HPV18 VIRUSES AND AT LEAST ONE OTHER TYPE OF HPV SELECTED AMONG HPV 31, 45 OR 52 | |
WO2006019841A3 (en) | Treatment of viral infections with egr 1 activators | |
SI1572233T1 (en) | Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | |
EP1901071A4 (en) | Methods of diagnosing, preventing and treating infection with hepatitis c virus | |
WO2006114273A3 (en) | Vaccine | |
AU2003240866A1 (en) | Antibodies, peptides and vaccines against hiv-1 virus | |
WO2008070332A3 (en) | Feline influenza vaccine and method of use | |
FI20050246A0 (en) | Diagnosis of viruses |